Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$63.7M
+4.6% from 2023
Prescriptions
5,416
$11,766.91 per claim
Patients
554
465 prescribers
Total spending, 2024
$63.7M
$115,035.35 per patient
Medicare prescription drug plans paid $63.7M for Glassia in 2024, for 5,416 prescriptions and refills to 554 patients (up 4.6% from 2023). The average cost per claim was $11,766.91.
Florida had the highest Medicare cost for Glassia in 2024: $6.6M for 558 claims, followed by Pennsylvania ($5.4M).
Mahmood Alam, pulmonary disease in Whitesburg, KY, had the highest Medicare cost for Glassia in 2024: 112 claims costing $1.6M.
Glassia is made by Takeda Pharmaceutical Company Limited (TAK), listed in the Medicare spending data as Baxalta US Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Mahmood Alam Whitesburg, KY | Pulmonary Disease | 112 | 14 | $1.6M |
| Maria R Boustani Beckley, WV | Pulmonary Disease | 107 | 12 | $1.3M |
| Daniel L Holt Washington, PA |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 436 | 5,194 | 508 | $60.6M |
| 2023 | 414 | 5,134 | 496 | $61.0M |
| 2024 | 465 | 5,416 | 554 | $63.7M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Family Practice |
| 100 |
| Under 11 |
| $1.3M |
| Douglas Hogarth Chicago, IL | Pulmonary Disease | 65 | Under 11 | $1.0M |
| Humam W Farah Hannibal, MO | Pulmonary Disease | 69 | Under 11 | $858K |
| Rhonda C Hillman Kingsport, TN | Nurse Practitioner | 54 | Under 11 | $832K |
| Lohaliz Bobe Port Charlotte, FL | Pulmonary Disease | 56 | Under 11 | $651K |
| Joshua N Aaron Elkton, MD | Pulmonary Disease | 46 | Under 11 | $601K |
| Emily K Rehberg Sylacauga, AL | Internal Medicine | 38 | Under 11 | $535K |
| Ayla Gordon Marietta, OH | Pulmonary Disease | 30 | Under 11 | $482K |
| Keesha Tyler Dothan, AL | Nurse Practitioner | 45 | Under 11 | $478K |
| Alan J Kanouff Altoona, PA | Critical Care (Intensivists) | 39 | Under 11 | $444K |
| Robert G Shellman Shelbyville, IN | Pulmonary Disease | 32 | Under 11 | $432K |
| James W Gainer Elkins, WV | Family Practice | 26 | Under 11 | $413K |
| Rafael A Martinez Tampa, FL | Pulmonary Disease | 35 | Under 11 | $398K |
| Eustace S Fernandes Fort Wayne, IN | Pulmonary Disease | 19 | Under 11 | $395K |
| Christopher G Lamb Saint George, UT | Nurse Practitioner | 30 | Under 11 | $395K |
| Raul Manuel B Cruz Olympia, WA | Pulmonary Disease | 13 | Under 11 | $384K |
| Christy L Martin Portsmouth, OH | Nurse Practitioner | 38 | Under 11 | $382K |
| Jason M Lawrence Fishersville, VA | Pulmonary Disease | 26 | Under 11 | $381K |
| Abbas Mansour Easley, SC | Pulmonary Disease | 39 | Under 11 | $374K |
| Sandeep Bansal Du Bois, PA | Pulmonary Disease | 26 | Under 11 | $368K |
| Podduturu S Reddy Port Huron, MI | Internal Medicine | 26 | Under 11 | $367K |
| Gordon S Warner Cullman, AL | Pulmonary Disease | 28 | Under 11 | $353K |
| Walid F Tanyous Venice, FL | Pulmonary Disease | 34 | Under 11 | $352K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Baxalta US Inc. TAK | 5,416 | $63.7M |